Printed from Voxsanity (voxsanity.com.au) — NCT07101679 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Pancreatic Cancer
Phase 2 Pancreatic Cancer Trial, Recruiting
NCT07101679
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a specific type of pancreatic cancer called pancreatic ductal adenocarcinoma, confirmed by tissue testing and imaging scans, and a specialist team has decided the tumor cannot be surgically removed
- You have not yet received any treatment for your cancer — including chemotherapy, radiation, surgery, or any other cancer therapy
- You are between 18 and 75 years old
- Your general health and ability to carry out daily activities falls within an acceptable range (confirm with trial site)
- Your tumor is large enough to be measured clearly on a scan
- Your blood, liver, kidney, and heart function all meet certain minimum levels shown through blood tests and other tests (confirm with trial site)
- You have no history of autoimmune disease (a condition where your immune system attacks your own body)
- Your doctor expects you to live for at least 3 more months
- You are willing and able to understand the trial and give your written agreement to take part
Who may not be able to join:
- You are allergic or have had a bad reaction to any of the medicines used in this trial
- Your cancer has spread to distant parts of your body (Stage IV)
- A specialist team has decided your tumor could potentially be removed or is on the borderline of being removable with surgery
- Your tumor is considered unsuitable for a specific type of targeted radiation treatment called SBRT (confirm with trial site)
- There is a known or suspected possibility that your cancer has spread to your brain or spinal cord
- You have been diagnosed with another cancer in the past 5 years (with some exceptions for certain minor skin cancers and early cervical conditions)
- You need to receive any other cancer treatments at the same time as this trial, such as chemotherapy, immunotherapy, targeted therapy, or certain herbal medicines with anti-cancer effects
- You have previously received chemotherapy or certain types of immunotherapy drugs (confirm with trial site for specific medicines)
- You have an immune system condition, or you have been taking steroid medicines or other immune-suppressing drugs recently
- You have received a live vaccine (such as those for measles, chickenpox, or yellow fever) within the past 30 days
- You have high blood pressure that has not been brought under control despite treatment
- You have serious heart problems, such as severe heart failure, a heart attack, or unstable chest pain within the past 6 months
- You have a heart rhythm problem that requires treatment
- You have had a stroke, blood clot in the lungs, or significant tumor bleeding in the past 6 months
- You need surgery within 28 days before starting or during the trial
- You have large amounts of fluid collecting in your chest or abdomen that is not well controlled
- You have a history of a hole or tear in your digestive tract, or are at risk of one
- You are taking certain other medications that may interfere with the trial drugs (confirm with trial site for specific medicines)
- You have a severe mental health condition
- You are pregnant, possibly pregnant, or currently breastfeeding
- You are able to become pregnant but are unwilling to use contraception during the trial and for 3 months after finishing
- You have taken part in another clinical drug or device trial within the past 4 weeks
- Your doctor has any other concern that makes joining this trial unsuitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
Contact this trial
Principal Investigator: Dan Cao, MD, Division of Abdominal Tumor, Department of Medical Oncology, Cancer Center and State Key Laboratory of Biological Therapy, West China Hospital, Sichuan University, Chengdu, Sichuan
Phone: +8618980605963
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 2
Sponsor
West China Hospital
Registry
ClinicalTrials.gov
Start date
16 April 2025
Est. completion
15 April 2027
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Investigator-assessed Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.